Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- HUMAN RESOURCES NEWS IN BRIEF
March 27, 2006
- Baraclude More Beneficial than Lamivudine for CHB
March 27, 2006
- Taisho to Increase Focus on Health & Beauty Business
March 27, 2006
- Sales Up 9.7% in 2005 Targeting Diabetes: Novo Nordisk
March 27, 2006
- US Study Shows Good Results for NM-702 Against ASO
March 27, 2006
- SELF-MEDICATION NEWS IN BRIEF
March 27, 2006
- Takeda Announces License Agreement for Tavocept in Japan
March 27, 2006
- 3 Bioventures to Jointly Develop Anticancer Agents
March 27, 2006
- MEDICAL DEVICE NEWS IN BRIEF
March 27, 2006
- NPhA Criticizes Takeda's Attitude toward Chain Pharmacies
March 27, 2006
- Korosho Submits Proposed GL for Animal Studies
March 27, 2006
- Hokuyaku, Takeyama to Integrate Management
March 27, 2006
- R&D NEWS IN BRIEF
March 27, 2006
- Industry Must Reject Price Reductions Not Based on Market Prices: JPMA President
March 20, 2006
- Pharmacies to Play a Greater Role: JPA Vice President
March 20, 2006
- Takeda Asks Wholesalers Not to Accept Proposals of Bundling from Pharmacy Chains
March 20, 2006
- JPA Presents Petition Regarding New OTC Drug Marketing System
March 20, 2006
- REGULATORY NEWS IN BRIEF
March 20, 2006
- Bill to Amend PAL Approved by Cabinet
March 20, 2006
- Kowa, Nikken Chemicals to Integrate Operations on Oct. 1
March 20, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…